Incretin Drugs and Muscle Loss: Why Lean Mass Decline May Not Mean Sarcopenia
A new perspective in Advances in Therapy argues that lean mass loss during incretin therapy reflects physiological body composition remodeling ...
A new perspective in Advances in Therapy argues that lean mass loss during incretin therapy reflects physiological body composition remodeling ...
A network meta-analysis of four randomized trials in 14,348 adults with type 2 diabetes finds that higher doses of tirzepatide ...
A meta-analysis of 19 high-potency incretin trials finds that objective signs of malnutrition and lean mass loss occur far more ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine